Be part of the knowledge.™

Global Oncology Academy

The Global Oncology Academy (GOA) is an educational platform for physicians and other healthcare professionals involved in oncology. Its mission is to increase knowledge regarding the disease course of specific cancers and address key elements for successful management. The GOA series will also share the science around innovations in combination therapies, oncology strategies, and new developments.

For more information about GOA, visit www.globaloncologyacademy.org.

796

LikeLikedUnlike

1-15 of 105

Treatment Decisions That Matter: Live Tumor Board in Advanced Ovarian Cancer
CME/CE Virtual Event
Treatment Decisions That Matter: Live Tumor Board in Advanced Ovarian Cancer
August 20, 2026
02:30 PM - 03:30 PM ET
1.00 credits
Treatment Decisions That Matter: Live Tumor Board in Advanced Ovarian Cancer
CME/CE Virtual Event
Treatment Decisions That Matter: Live Tumor Board in Advanced Ovarian Cancer
September 03, 2026
02:00 PM - 03:00 PM ET
1.00 credits
Treatment Decisions That Matter: Live Tumor Board in Advanced Ovarian Cancer
CME/CE Virtual Event
Treatment Decisions That Matter: Live Tumor Board in Advanced Ovarian Cancer
September 24, 2026
03:30 PM - 04:30 PM ET
1.00 credits
Precision Through the Continuum: Applying Biomarker-Guided Therapies in Ovarian Cancer
CME/CE
Precision Through the Continuum: Applying Biomarker-Guided Therapies in Ovarian Cancer
- Susana Campos, MD, MPH
- Robert Coleman, MD, FACOG
- Debra Richardson, MD
1.00 credits
The Future of mCSPC: Molecular Profiling and Biomarker-Directed Therapies
CME/CE
The Future of mCSPC: Molecular Profiling and Biomarker-Directed Therapies
- Neeraj Agarwal, MD, FASCO
- Rana McKay, MD
0.25 credits
Cracking the Code in Localized, nmCSPC: Risk, Treatment, and Timing
CME/CE
Cracking the Code in Localized, nmCSPC: Risk, Treatment, and Timing
- Neeraj Agarwal, MD, FASCO
- Rana McKay, MD
0.25 credits
advertisement
Case: Implementing ADT Intensification in mHSPC
MinuteCE®
Case: Implementing ADT Intensification in mHSPC
- Scott T. Tagawa, MD, MS
- Mary-Ellen Taplin, MD
1.00 program credits
Targeting PTEN: Why It Matters
MinuteCE®
Targeting PTEN: Why It Matters
- Scott T. Tagawa, MD, MS
- Mary-Ellen Taplin, MD
1.00 program credits
MinuteCE®
Treatment Intensification in HSPC: From Risk Stratification to Precision Medicine
- Scott T. Tagawa, MD, MS
- Mary-Ellen Taplin, MD
1.00 credits 6 episodes
Winning the Battle Against Side Effects: Adverse Event Management in HSPC
MinuteCE®
Winning the Battle Against Side Effects: Adverse Event Management in HSPC
- Scott T. Tagawa, MD, MS
- Mary-Ellen Taplin, MD
1.00 program credits
ADT Intensification: The Evidence You Can’t Afford to Miss
MinuteCE®
ADT Intensification: The Evidence You Can’t Afford to Miss
- Scott T. Tagawa, MD, MS
- Mary-Ellen Taplin, MD
1.00 program credits
De Novo mHSPC: Recognizing the Patients Who Need More
MinuteCE®
De Novo mHSPC: Recognizing the Patients Who Need More
- Scott T. Tagawa, MD, MS
- Mary-Ellen Taplin, MD
1.00 program credits
advertisement
Molecular Profiling in mHSPC: Informing Treatment Selection
MinuteCE®
Molecular Profiling in mHSPC: Informing Treatment Selection
- Scott T. Tagawa, MD, MS
- Mary-Ellen Taplin, MD
1.00 program credits
SERENA-6: Acting on ESR1 Mutations in Advanced Breast Cancer
MinuteCE®
SERENA-6: Acting on ESR1 Mutations in Advanced Breast Cancer
- Erica L. Mayer, MD, MPH
0.50 program credits
ELEVATE: Elacestrant Plus Capivasertib in Advanced Breast Cancer
MinuteCE®
ELEVATE: Elacestrant Plus Capivasertib in Advanced Breast Cancer
- Aditya Bardia, MD, MPH, FASCO
0.50 program credits

Program Chapters

Segment Chapters

Playlist:

Recommended